Big Move For GBS Inc.
Tue, Mar 01, 2022 at 05:30 PM
GBS Inc. (GBS:NASDAQ) rocketted at $0.69, representing a gain of 50%. The stock got featured on our News Catalysts scanner on Tue, Feb 15, 2022 at 11:18 AM in the 'EARNINGS' category. From Tue, Feb 15, 2022, the stock recorded 25.00% Up Days and 22.22% Green Days
The stock spiked on Mon, Jan 03, 2022 at $1.98 with a volume of 7M+.
About GBS Inc. (GBS:NASDAQ)
GBS Inc is a United States-based company engaged in manufacturing of Saliva Glucose Biosensor (SGB). SGB uses saliva to measure glucose non-invasively.
Top 10 Gainers:
- Viscogliosi Brothers Acquisition Corp (VBOC:NASDAQ), 100%
- Avenue Therapeutics, Inc. (ATXI:NASDAQ), 78.46%
- CTI BioPharma Corp. (CTIC:NASDAQ), 63.16%
- GBS Inc. (GBS:NASDAQ), 50%
- Guardion Health Sciences, Inc. (GHSI:NASDAQ), 47.84%
- CooTek (Cayman) Inc. (CTK:NYSE), 36.24%
- Trevi Therapeutics, Inc. (TRVI:NASDAQ), 36.11%
- Sky Harbour Group Corporation Class A (SKYH:NYSEMKT), 30.84%
- GWG Holdings, Inc. (GWGH:NASDAQ), 29.37%
- Avinger, Inc. (AVGR:NASDAQ), 28.31%